A recent survey from the Kaiser Family Foundation found three-quarters of Americans support the idea of including drug prices in direct-to-consumer advertisements.
The survey, according to an MM&M report, reported 83 percent of Democrats, 73 percent of independents and 72 percent of Republicans support the idea proposed by Health and Human Services Secretary Alex Azar in a drug pricing blueprint released in May.
Of the some 14 percent of people who reported seeing or hearing a drug ad in the past year, 55 percent were prescribed the drugs following an appointment with a physician. A little less than half, around 48 percent, discussed the drug’s price with their doctor.
MM&M, citing data from Kantar Media, reports pharmaceutical companies spent about $6.1 billion on direct-to-consumer advertisements in 2017.